Neutralizing prolactin receptor antibodies and their therapeutic use

Details for Australian Patent Application No. 2010330161 (hide)

Owner Bayer Intellectual Property GmbH

Inventors Otto, Christiane; Wolf, Siegmund; Freiberg, Christoph; Harrenga, Axel; Greven, Simone; Trautwein, Mark; Bruder, Sandra; Eicker, Andrea; Wilmen, Andreas

Agent Davies Collison Cave

Pub. Number AU-A-2010330161

PCT Pub. Number WO2011/069795

Priority 09075546.3 10.12.09 EP

Filing date 18 November 2010

Wipo publication date 16 June 2011

International Classifications

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 5/08 Drugs for disorders of the endocrine system

A61P 35/00 Antineoplastic agents

Event Publications

5 July 2012 PCT application entered the National Phase

  PCT publication WO2011/069795 Priority application(s): WO2011/069795

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010330165-Neutralizing prolactin receptor antibodies and their therapeutic use

2010330131-Power plant with C02 capture and method to operate such power plant